Encephalopathy, Hypoxic-Ischemic Clinical Trial
— PEDI-REAVASCOfficial title:
Quantitative Assessment of Cerebral Vascular Reactivity by Resting Functional Magnetic Resonance Imaging of Infants With Hypoxic Ischemic Encephalopathy After Hypothermia Treatment: Diagnostic and Prognostic Implications.
Verified date | April 2024 |
Source | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a prospective, observational, single-center study to assess the correlation between rs-fMRI measures and clinical measures of standard MRI, NIRS, EEG and clinical scores. The target population was neonates with HIE referred to MRI after hypothermia treatment, which was initiated within 6 hours of birth, continued for 72 hours and followed by a slow rewarming period of 6-12 hours. A one-year clinical and imaging follow-up is planned. As the aim of the present study is to assess the predictiveness of the outcome one year after the HIE event, no follow-up is planned.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | October 1, 2025 |
Est. primary completion date | September 15, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Hour to 14 Months |
Eligibility | Inclusion Criteria: Newborns at 36 weeks gestation or more, with HIE treated with therapeutic hypothermia will be prospectively included. Exclusion Criteria: - Lack of parental consent - Congenital anomalies that make hypothermia treatment not indicated - Coagulopathy with active bleeding |
Country | Name | City | State |
---|---|---|---|
Belgium | Cliniques Universitaires Saint Luc | Brussels |
Lead Sponsor | Collaborator |
---|---|
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | quantifying cerebrovascular reactivity (CVR) by resting-state functional MRI (r-fMRI) in infants with moderate to severe hypoxic-ischaemic encephalopathy (HIE) | Correlation between RCV mapping EEG/MRI | at birth, directly after hypothermia and at 1 year of baby's life |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01192776 -
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
|
N/A | |
Completed |
NCT01862250 -
Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
|
Phase 1/Phase 2 | |
Completed |
NCT01793129 -
Preemie Hypothermia for Neonatal Encephalopathy
|
N/A | |
Recruiting |
NCT03162653 -
Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
|
Phase 3 | |
Completed |
NCT00614744 -
Late Hypothermia for Hypoxic-Ischemic Encephalopathy
|
N/A |